Morcher Gmbh:企業の製品パイプライン分析2018

◆英語タイトル:Morcher Gmbh - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12767
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Morcher Gmbh (Morcher) is a medical device company that develops, manufactures, and distributes implants for cataract surgery. The company’s products include capsular tension rings, eyejet ctr – preloaded capsular tension rings, cionni rings for scleral fixation, capsular segment for scleral fixation, capsular edge rings, aniridia rings, partial aniridia rings, aniridia implants, and partial aniridia implants. Its services include consulting, development, construction, prototyping, OEM-manufacturing, tool-manufacturing, and raw-materials. Morcher offers special implants such as diplopia implants, pupil dilators, bean rings, and intraocular implant. The company manufactures medical devices for eye surgery and the related ophthalmology. Morcher is headquartered in Stuttgart, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Morcher Gmbh
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Morcher Gmbh Company Overview 6
Morcher Gmbh Company Snapshot 6
Morcher Gmbh Pipeline Products and Ongoing Clinical Trials Overview 6
Morcher Gmbh – Pipeline Analysis Overview 9
Morcher Gmbh – Key Facts 9
Morcher Gmbh – Major Products and Services 10
Morcher Gmbh Pipeline Products by Development Stage 11
Morcher Gmbh Pipeline Products Overview 14
Aniridia Implant TYPE 67B 14
Aniridia Implant TYPE 67B Product Overview 14
Aniridia Implants TYPE 67F 15
Aniridia Implants TYPE 67F Product Overview 15
Aniridia Implants TYPE 67G 16
Aniridia Implants TYPE 67G Product Overview 16
Aniridia Implants TYPE 67L 17
Aniridia Implants TYPE 67L Product Overview 17
Aniridia Implants TYPE 68 18
Aniridia Implants TYPE 68 Product Overview 18
Aniridia Implants TYPE 94A 19
Aniridia Implants TYPE 94A Product Overview 19
Aniridia Rings TYPE 50C 20
Aniridia Rings TYPE 50C Product Overview 20
Aniridia Rings Type 50E 21
Aniridia Rings Type 50E Product Overview 21
Aniridia Rings TYPE 50F 22
Aniridia Rings TYPE 50F Product Overview 22
Aniridia Rings TYPE 96C 23
Aniridia Rings TYPE 96C Product Overview 23
Anterior Chamber IOL TYPE 54A 24
Anterior Chamber IOL TYPE 54A Product Overview 24
Anterior Chamber IOL TYPE 54B 25
Anterior Chamber IOL TYPE 54B Product Overview 25
Anterior Chamber IOLs TYPE 54 26
Anterior Chamber IOLs TYPE 54 Product Overview 26
Diplopia IOLs TYPE 85F 27
Diplopia IOLs TYPE 85F Product Overview 27
Makula IOL TYPE 25B 28
Makula IOL TYPE 25B Product Overview 28
Microophthalmus IOLs TYPE 27D 29
Microophthalmus IOLs TYPE 27D Product Overview 29
Myopia IOLs TYPE 22S 30
Myopia IOLs TYPE 22S Product Overview 30
Myopia IOLs TYPE 71A 31
Myopia IOLs TYPE 71A Product Overview 31
Myopia IOLs TYPE 71B 32
Myopia IOLs TYPE 71B Product Overview 32
Partial Aniridia Implants Type 67 33
Partial Aniridia Implants Type 67 Product Overview 33
Partial Aniridia Implants Type 67A 34
Partial Aniridia Implants Type 67A Product Overview 34
Partial Aniridia Implants Type 67D 35
Partial Aniridia Implants Type 67D Product Overview 35
Partial Aniridia Implants Type 67E 36
Partial Aniridia Implants Type 67E Product Overview 36
Partial Aniridia Implants Type 67S 37
Partial Aniridia Implants Type 67S Product Overview 37
Partial Aniridia Implants Type 68C 38
Partial Aniridia Implants Type 68C Product Overview 38
Partial Aniridia Implants TYPE 94 39
Partial Aniridia Implants TYPE 94 Product Overview 39
Partial Aniridia Implants TYPE 94C 40
Partial Aniridia Implants TYPE 94C Product Overview 40
Partial Aniridia Ring TYPE 94G 41
Partial Aniridia Ring TYPE 94G Product Overview 41
Partial Aniridia Ring TYPE 96E 42
Partial Aniridia Ring TYPE 96E Product Overview 42
Partial Aniridia Ring TYPE 96F 43
Partial Aniridia Ring TYPE 96F Product Overview 43
Partial Aniridia Ring TYPE 96G 44
Partial Aniridia Ring TYPE 96G Product Overview 44
Phakic IOLs TYPE 99A 45
Phakic IOLs TYPE 99A Product Overview 45
Phakic IOLs TYPE 99B 46
Phakic IOLs TYPE 99B Product Overview 46
Phakic IOLs TYPE 99C 47
Phakic IOLs TYPE 99C Product Overview 47
Phakic IOLs TYPE 99D 48
Phakic IOLs TYPE 99D Product Overview 48
Pinhole Intraocular Implant 49
Pinhole Intraocular Implant Product Overview 49
Sclera IOLs Type 27L 50
Sclera IOLs Type 27L Product Overview 50
Sclera IOLs Type 53S 51
Sclera IOLs Type 53S Product Overview 51
Sclera IOLs Type 66 52
Sclera IOLs Type 66 Product Overview 52
Sclera IOLs Type 81B 53
Sclera IOLs Type 81B Product Overview 53
Sclera One Piece IOLs TYPE 90L 54
Sclera One Piece IOLs TYPE 90L Product Overview 54
Morcher Gmbh – Key Competitors 55
Morcher Gmbh – Key Employees 56
Morcher Gmbh – Locations And Subsidiaries 57
Head Office 57
Appendix 58
Methodology 58
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Morcher Gmbh Pipeline Products and Ongoing Clinical Trials Overview 6
Morcher Gmbh Pipeline Products by Equipment Type 7
Morcher Gmbh Pipeline Products by Indication 8
Morcher Gmbh, Key Facts 9
Morcher Gmbh, Major Products and Services 10
Morcher Gmbh Number of Pipeline Products by Development Stage 11
Morcher Gmbh Pipeline Products Summary by Development Stage 12
Aniridia Implant TYPE 67B - Product Status 14
Aniridia Implant TYPE 67B - Product Description 14
Aniridia Implants TYPE 67F - Product Status 15
Aniridia Implants TYPE 67F - Product Description 15
Aniridia Implants TYPE 67G - Product Status 16
Aniridia Implants TYPE 67G - Product Description 16
Aniridia Implants TYPE 67L - Product Status 17
Aniridia Implants TYPE 67L - Product Description 17
Aniridia Implants TYPE 68 - Product Status 18
Aniridia Implants TYPE 68 - Product Description 18
Aniridia Implants TYPE 94A - Product Status 19
Aniridia Implants TYPE 94A - Product Description 19
Aniridia Rings TYPE 50C - Product Status 20
Aniridia Rings TYPE 50C - Product Description 20
Aniridia Rings Type 50E - Product Status 21
Aniridia Rings Type 50E - Product Description 21
Aniridia Rings TYPE 50F - Product Status 22
Aniridia Rings TYPE 50F - Product Description 22
Aniridia Rings TYPE 96C - Product Status 23
Aniridia Rings TYPE 96C - Product Description 23
Anterior Chamber IOL TYPE 54A - Product Status 24
Anterior Chamber IOL TYPE 54A - Product Description 24
Anterior Chamber IOL TYPE 54B - Product Status 25
Anterior Chamber IOL TYPE 54B - Product Description 25
Anterior Chamber IOLs TYPE 54 - Product Status 26
Anterior Chamber IOLs TYPE 54 - Product Description 26
Diplopia IOLs TYPE 85F - Product Status 27
Diplopia IOLs TYPE 85F - Product Description 27
Makula IOL TYPE 25B - Product Status 28
Makula IOL TYPE 25B - Product Description 28
Microophthalmus IOLs TYPE 27D - Product Status 29
Microophthalmus IOLs TYPE 27D - Product Description 29
Myopia IOLs TYPE 22S - Product Status 30
Myopia IOLs TYPE 22S - Product Description 30
Myopia IOLs TYPE 71A - Product Status 31
Myopia IOLs TYPE 71A - Product Description 31
Myopia IOLs TYPE 71B - Product Status 32
Myopia IOLs TYPE 71B - Product Description 32
Partial Aniridia Implants Type 67 - Product Status 33
Partial Aniridia Implants Type 67 - Product Description 33
Partial Aniridia Implants Type 67A - Product Status 34
Partial Aniridia Implants Type 67A - Product Description 34
Partial Aniridia Implants Type 67D - Product Status 35
Partial Aniridia Implants Type 67D - Product Description 35
Partial Aniridia Implants Type 67E - Product Status 36
Partial Aniridia Implants Type 67E - Product Description 36
Partial Aniridia Implants Type 67S - Product Status 37
Partial Aniridia Implants Type 67S - Product Description 37
Partial Aniridia Implants Type 68C - Product Status 38
Partial Aniridia Implants Type 68C - Product Description 38
Partial Aniridia Implants TYPE 94 - Product Status 39
Partial Aniridia Implants TYPE 94 - Product Description 39
Partial Aniridia Implants TYPE 94C - Product Status 40
Partial Aniridia Implants TYPE 94C - Product Description 40
Partial Aniridia Ring TYPE 94G - Product Status 41
Partial Aniridia Ring TYPE 94G - Product Description 41
Partial Aniridia Ring TYPE 96E - Product Status 42
Partial Aniridia Ring TYPE 96E - Product Description 42
Partial Aniridia Ring TYPE 96F - Product Status 43
Partial Aniridia Ring TYPE 96F - Product Description 43
Partial Aniridia Ring TYPE 96G - Product Status 44
Partial Aniridia Ring TYPE 96G - Product Description 44
Phakic IOLs TYPE 99A - Product Status 45
Phakic IOLs TYPE 99A - Product Description 45
Phakic IOLs TYPE 99B - Product Status 46
Phakic IOLs TYPE 99B - Product Description 46
Phakic IOLs TYPE 99C - Product Status 47
Phakic IOLs TYPE 99C - Product Description 47
Phakic IOLs TYPE 99D - Product Status 48
Phakic IOLs TYPE 99D - Product Description 48
Pinhole Intraocular Implant - Product Status 49
Pinhole Intraocular Implant - Product Description 49
Sclera IOLs Type 27L - Product Status 50
Sclera IOLs Type 27L - Product Description 50
Sclera IOLs Type 53S - Product Status 51
Sclera IOLs Type 53S - Product Description 51
Sclera IOLs Type 66 - Product Status 52
Sclera IOLs Type 66 - Product Description 52
Sclera IOLs Type 81B - Product Status 53
Sclera IOLs Type 81B - Product Description 53
Sclera One Piece IOLs TYPE 90L - Product Status 54
Sclera One Piece IOLs TYPE 90L - Product Description 54
Morcher Gmbh, Key Employees 56
Glossary 60

List of Figures
Morcher Gmbh Pipeline Products by Equipment Type 7
Morcher Gmbh Pipeline Products by Development Stage 11

★海外企業調査レポート[Morcher Gmbh:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Companhia Energetica de Sao Paulo (CESP6):電力:M&Aディール及び事業提携情報
    Summary Companhia Energetica de Sao Paulo (CESP) is a state-owned integrated electric utility. It plans, constructs, and operates electric energy generation and commercialization systems. The company produces energy using hydro source. CESP owns power plants at Rio Paran, Rio Paraibuna, and Rio Jagu …
  • Protonex Technology Corporation:企業の戦略的SWOT分析
    Protonex Technology Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Falck Renewables S.p.A. (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables S.p.A. (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • maxingvest ag:企業の戦略・SWOT・財務分析
    Summarymaxingvest ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Oramed Pharmaceuticals Inc (ORMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique …
  • Fubon Financial Holding Co Ltd.:企業の戦略・SWOT・財務分析
    SummaryFubon Financial Holding Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • Gazpromneft-Moscow Oil Refinery (GZNP):企業の財務及び戦略的SWOT分析
    Summary Gazpromneft-Moscow Oil Refinery (Gazpromneft-MOR), a subsidiary of Gazprom Neft is an oil refinery that produces oil and petroleum products. The company offers products such as high-octane gasoline, diesel fuels, construction bitumen, fuel oil, and motor fuel. It also provides construction a …
  • Quaterra Resources Inc (QTA):企業の財務・戦略的SWOT分析
    Summary Quaterra Resources Inc (Quaterra Resources) is a copper exploration company that acquires and operates copper projects. The company's activities include acquisition, exploration and development of gold, silver, and copper deposits in Canada. Its projects comprise Quaterra’s Yerington Copper …
  • DexCom, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DexCom, Inc. Mergers and Acquis …
  • 99 Cents Only Stores LLC:企業概要及び戦略的SWOT分析
    99 Cents Only Stores LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Bank of Ningbo Co. Ltd.:企業の戦略・SWOT・財務分析
    SummaryBank of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Canadian Real Estate Investment Trust (REF.UN):企業財務及び戦略的SWOT分析
    Summary Canadian Real Estate Investment Trust (CREIT) is a financial services company that provides real estate investment services. The company offers portfolio of real estate assets and provides delivery of benefits to real estate ownership and their investors. It provides tenant resourcing and le …
  • Medwell Capital Corp. (GDI):企業の財務及び戦略的SWOT分析
    Summary Medwell Capital Corp. (Medwell), formerly BioMS Medical Corp is a financial service provider that offers capital, investment and advisory services. The company invests in healthcare industries. It holds and manages investments through its subsidiaries. Medwell is headquartered in Edmonton, A …
  • The Great-West Life Assurance Company(エネルギー分野):企業M&A動向
    Summary The Great-West Life Assurance Company (Great -West Life), a subsidiary of Great-West Lifeco Inc., is a Canadian insurer with interests in life insurance, health insurance, investments, savings, retirement income and reinsurance businesses. For individuals, it offers life insurance, disabilit …
  • Rentschler Holding GmbH and Co. KG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rentschler Holding GmbH and Co. …
  • Caladrius Biosciences Inc (CLBS):企業財務及び戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem, Inc., develops and manufactures cell therapy products. Its products are based on its proprietary technologies, Dendritic Cell-Tumor Cell technology; CD34 technology; and T Regulatory technology, for immuno-oncology, ischemic repair and …
  • Claris Lifesciences Ltd (533288)-製薬・医療分野:企業M&A・提携分析
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company offers generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. Its products are offered through various delivery sys …
  • PanaHome Corp:企業の戦略的SWOT分析
    PanaHome Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Maerki Baumann & Co. AG:企業の戦略・SWOT・財務情報
    Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Hartford Financial Services Group, Inc.:戦略・SWOT・企業財務分析
    The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆